Infectious Disease Alert – March 1, 2008
March 1, 2008
View Issues
-
Relationship between Tenofovir-Associated Renal Dysfunction and HAART Regimen
This study from the California collaborative treatment Group examined renal function over time in 146 patients included in the CCTG 578 prospective, randomized clinical trial of therapeutic drug monitoring (TDM). -
A New Class of Antiretrovirals: Isentress® (Raltegravir)
Over the past decade, tremendous progress has been made to increase the tolerability of treatment regimens and to reduce the pill burden for HIV-1 infected patients. -
S. maltophilia: A Multi-Resistant Nosocomial Pathogen
Stenotrophomonas maltophilia (formerly known as Pseudomonas maltophilia, Xanthomonas maltophilia) is a motile, gram-negative bacillus that is widely distributed in nature, particularly in water and soil. -
Updates by Carol A. Kemper, MD, FACP
In a news conference February 8, 2008, officials from the CDC announced that preliminary data suggest there is a mismatch between circulating influenza virus in the United States this winter and this year's influenza vaccine.